Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancerBritish journal of cancer, 2019-09, Vol.121 (6), p.490-496 [Peer Reviewed Journal]Copyright Nature Publishing Group Sep 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0541-3 ;PMID: 31388183Full text available |
|
2 |
Material Type: Article
|
Metformin use and lung cancer survival: a population-based study in NorwayBritish journal of cancer, 2021-03, Vol.124 (5), p.1018-1025 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01186-9 ;PMID: 33262518Full text available |
|
3 |
Material Type: Article
|
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancerBritish journal of cancer, 2019-10, Vol.121 (9), p.725-737 [Peer Reviewed Journal]Copyright Nature Publishing Group Oct 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0573-8 ;PMID: 31564718Full text available |
|
4 |
Material Type: Article
|
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancerBritish journal of cancer, 2018-01, Vol.118 (1), p.32-37 [Peer Reviewed Journal]Copyright Nature Publishing Group Jan 9, 2018 ;Copyright © 2018 Cancer Research UK 2018 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2017.394 ;PMID: 29190637Full text available |
|
5 |
Material Type: Article
|
Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung CancerAsian Pacific journal of cancer prevention : APJCP, 2021-08, Vol.22 (8), p.2569-2576 [Peer Reviewed Journal]ISSN: 1513-7368 ;EISSN: 2476-762X ;DOI: 10.31557/APJCP.2021.22.8.2569 ;PMID: 34452572Full text available |
|
6 |
Material Type: Article
|
Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesisBritish journal of cancer, 2020-03, Vol.122 (7), p.1050-1058 [Peer Reviewed Journal]2020© The Author(s), under exclusive licence to Cancer Research UK 2020 ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0742-9 ;PMID: 32020063Full text available |
|
7 |
Material Type: Article
|
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150British journal of cancer, 2022-01, Vol.126 (1), p.42-47 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;The Author(s), under exclusive licence to Springer Nature Limited 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01606-4 ;PMID: 34711947Full text available |
|
8 |
Material Type: Article
|
Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancerOncotarget, 2017-01, Vol.8 (5), p.8738-8751Copyright: © 2017 Inoue et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.14434 ;PMID: 28060732Full text available |
|
9 |
Material Type: Article
|
Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancerBritish journal of cancer, 2019-04, Vol.120 (9), p.903-912 [Peer Reviewed Journal]Cancer Research UK 2019. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0444-3 ;PMID: 30956278Full text available |
|
10 |
Material Type: Article
|
Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survivalBritish journal of cancer, 2022-02, Vol.126 (3), p.409-418 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;The Author(s), under exclusive licence to Springer Nature Limited 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01634-0 ;PMID: 34848855Full text available |
|
11 |
Material Type: Article
|
Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2Oncotarget, 2015-12, Vol.6 (39), p.41692-41705Copyright: © 2015 Tung et al. 2015 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.6150 ;PMID: 26497680Full text available |
|
12 |
Material Type: Article
|
Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltrationBritish journal of cancer, 2020-04, Vol.122 (8), p.1205-1210 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0756-3 ;PMID: 32066909Full text available |
|
13 |
Material Type: Article
|
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerBritish journal of cancer, 2017-08, Vol.117 (5), p.744-751 [Peer Reviewed Journal]Copyright Nature Publishing Group Aug 22, 2017 ;Copyright © 2017 Cancer Research UK 2017 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2017.232 ;PMID: 28728168Full text available |
|
14 |
Material Type: Article
|
Alterations of immune response of Non-Small Cell Lung Cancer with AzacytidineOncotarget, 2013-11, Vol.4 (11), p.2067-2079Copyright: © 2013 Wrangle et al. 2013 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.1542 ;PMID: 24162015Full text available |
|
15 |
Material Type: Article
|
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsBritish journal of cancer, 2015-01, Vol.112 (1), p.95-102 [Peer Reviewed Journal]Copyright Nature Publishing Group Jan 6, 2015 ;Copyright © 2015 Cancer Research UK 2015 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.555 ;PMID: 25349974 ;CODEN: BJCAAIFull text available |
|
16 |
Material Type: Article
|
CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cellsBritish journal of cancer, 2020-12, Vol.123 (12), p.1737-1748 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01088-w ;PMID: 32958825Full text available |
|
17 |
Material Type: Article
|
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancerOncotarget, 2016-05, Vol.7 (22), p.32113-32128Copyright: © 2016 Inoue et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.8528 ;PMID: 27050074Full text available |
|
18 |
Material Type: Article
|
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancerBritish journal of cancer, 2021-05, Vol.124 (10), p.1680-1689 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2021. ;The Author(s), under exclusive licence to Cancer Research UK 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01307-y ;PMID: 33723388Full text available |
|
19 |
Material Type: Article
|
Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancerBritish journal of cancer, 2020-12, Vol.123 (Suppl 1), p.10-17 [Peer Reviewed Journal]The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01070-6 ;PMID: 33293671Full text available |
|
20 |
Material Type: Article
|
Prognosis in HIV-infected patients with non-small cell lung cancerBritish journal of cancer, 2013-10, Vol.109 (7), p.1974-1980 [Peer Reviewed Journal]2014 INIST-CNRS ;Copyright Nature Publishing Group Oct 1, 2013 ;Copyright © 2013 Cancer Research UK 2013 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.545 ;PMID: 24022194 ;CODEN: BJCAAIFull text available |